Stage III non-small cell lung cancer represents a heterogeneous group of patients who are best managed with a multidisciplinary approach, including evaluation for surgical, radiation, and chemotherapeutic options.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.soc.2012.12.014 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!